CureVac NV

CureVac is a German biopharmaceutical company that develops messenger RNA therapies. It invents, tests and markets infectious disease vaccines and works on cancer drugs.

Founded in 2000 in Germany, CVAC.O seeks to revolutionize medicine by developing therapies that allow humans’ bodies to self-produce the auto-medications they need to heal themself.

Traders around the world use FxPro to closely monitor CureVac stock prices, and clients can buy or sell an asset as a CFD.

On the page above, there is an online quote chart, as well as trading conditions applicable to this security.

For effective trading on the stock market, we recommend checking the stock prices regularly. Also, follow the corporate reports and news about the company's activities that are published on major analytical portals.

Please note that in the case companies issue a dividend, the ex-dividend date, that is the date without entitlement to the dividend, is known in advance and is displayed in the corresponding calendar on our website. If you have a Buy position open on the ex-dividend date, your trading account will be credited with the dividend net of any withholding taxes. In the case of holding a Sell position, the whole dividend will be debited to your account. If you have questions about this, our customer support team are on hand to assist.

Start Trading CVAC.O CFD Stocks with FxPro Today!